|

PF-08653944 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MET097

Pipeline

Phase 3: 1

Top Sponsors

  • Pfizer1

Indications

  • Overweight and/or Obesity1
  • Diabetes Type 21
  • Diabetes1
  • Type 2 Diabetes1
  • Overweight1

Anaheim, California1 trial

A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

CenExel Anaheim Clinical Trials

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.